Cellenkos
Cellenkos is a clinical-stage biotech company focused on the development and commercialization of transformative novel allogeneic Treg cell therapies to treat autoimmune and inflammatory disorders.
Domain
cellenkosinc.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$15.0M
Founded
2015
Tech Stack (14 technologies)
Frequently Asked Questions
What technologies does Cellenkos use?+
Cellenkos uses 14 technologies including Google Analytics, Google Tag Manager, Nuxt.js.
What industry is Cellenkos in?+
Cellenkos operates in the Biotechnology industry.
Where is Cellenkos based?+
Cellenkos is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026